North Sea Therapeutics Appoints Melissa Bradford Klug As Chief Financial Officer and Chief Business Officer, and Sophie Jeannin As Chief Medical Officer

Feb 20, 2025•10 months ago

Position

Chief Medical Officer

Company

NorthSea Therapeutics

Sophie Jeannin

AmsterdamBiotechnologyHealth Care

Description

NorthSea Therapeutics announced the appointments of Melissa Bradford-Klug as the Chief Financial Officer and Chief Business Officer, and Sophie Jeannin as the Chief Medical Officer. These appointments bring a combination of strategic leadership capabilities and deep expertise in biotechnology innovation to NorthSea’s team at a pivotal stage.

Company Information

Company

NorthSea Therapeutics

Location

Amsterdam, North Holland, Netherlands

About

NorthSea Therapeutics is a clinical-stage biotech company located in the US and Europe. The company focuses on developing novel therapeutic strategies for orphan metabolic, inflammatory, and fibrotic diseases. As a forward-thinking organization, NorthSea Therapeutics is dedicated to advancing the field of healthcare through innovative solutions.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

North Sea Therapeutics Appoints Melissa Bradford Klug As Chief Financial Officer and Chief Business Officer, and Sophie Jeannin As Chief Medical Officer

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Executive Insights

Company Information